CN114190476A - Composition for helping pets to improve athletic ability and promote recovery after exercise - Google Patents
Composition for helping pets to improve athletic ability and promote recovery after exercise Download PDFInfo
- Publication number
- CN114190476A CN114190476A CN202111307564.6A CN202111307564A CN114190476A CN 114190476 A CN114190476 A CN 114190476A CN 202111307564 A CN202111307564 A CN 202111307564A CN 114190476 A CN114190476 A CN 114190476A
- Authority
- CN
- China
- Prior art keywords
- weight
- exercise
- percent
- creatine
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 36
- 238000011084 recovery Methods 0.000 title claims abstract description 24
- 230000000386 athletic effect Effects 0.000 title abstract description 15
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 claims abstract description 54
- 229960003624 creatine Drugs 0.000 claims abstract description 27
- 239000006046 creatine Substances 0.000 claims abstract description 27
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 19
- TTWYZDPBDWHJOR-IDIVVRGQSA-L adenosine triphosphate disodium Chemical compound [Na+].[Na+].C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O TTWYZDPBDWHJOR-IDIVVRGQSA-L 0.000 claims abstract description 17
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 16
- 239000008103 glucose Substances 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 230000004217 heart function Effects 0.000 claims abstract description 10
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 9
- 235000015872 dietary supplement Nutrition 0.000 claims abstract description 8
- 239000012752 auxiliary agent Substances 0.000 claims abstract description 7
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract description 5
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical group COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims abstract description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 18
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 14
- 239000000843 powder Substances 0.000 claims description 14
- 102000007544 Whey Proteins Human genes 0.000 claims description 12
- 108010046377 Whey Proteins Proteins 0.000 claims description 12
- 235000021119 whey protein Nutrition 0.000 claims description 12
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical group CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 9
- 229960003080 taurine Drugs 0.000 claims description 9
- 229940042585 tocopherol acetate Drugs 0.000 claims description 9
- 230000003078 antioxidant effect Effects 0.000 claims description 8
- 235000006708 antioxidants Nutrition 0.000 claims description 8
- 239000002211 L-ascorbic acid Substances 0.000 claims description 7
- 235000000069 L-ascorbic acid Nutrition 0.000 claims description 7
- 150000001413 amino acids Chemical class 0.000 claims description 7
- 229960005070 ascorbic acid Drugs 0.000 claims description 7
- 239000000047 product Substances 0.000 claims description 7
- 229940088594 vitamin Drugs 0.000 claims description 7
- 239000011782 vitamin Substances 0.000 claims description 7
- 229930003231 vitamin Natural products 0.000 claims description 7
- 235000013343 vitamin Nutrition 0.000 claims description 6
- 239000002366 mineral element Substances 0.000 claims description 4
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 4
- 235000013824 polyphenols Nutrition 0.000 claims description 4
- 239000003623 enhancer Substances 0.000 claims description 3
- 230000001737 promoting effect Effects 0.000 claims description 3
- 235000017471 coenzyme Q10 Nutrition 0.000 claims description 2
- 235000013325 dietary fiber Nutrition 0.000 claims description 2
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims 1
- 241001122767 Theaceae Species 0.000 claims 1
- 230000037147 athletic performance Effects 0.000 claims 1
- 229940110767 coenzyme Q10 Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000005515 coenzyme Substances 0.000 abstract description 8
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 abstract description 4
- 230000036541 health Effects 0.000 abstract description 4
- 239000002126 C01EB10 - Adenosine Substances 0.000 abstract description 2
- 229960005305 adenosine Drugs 0.000 abstract description 2
- 235000019728 animal nutrition Nutrition 0.000 abstract description 2
- YVBGRQLITPHVOP-UHFFFAOYSA-L disodium;[hydroxy-[hydroxy(oxido)phosphoryl]oxyphosphoryl] hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])(=O)OP(O)(=O)OP(O)([O-])=O YVBGRQLITPHVOP-UHFFFAOYSA-L 0.000 abstract description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 26
- 238000012360 testing method Methods 0.000 description 26
- 241000700159 Rattus Species 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 17
- 239000008280 blood Substances 0.000 description 17
- 241001465754 Metazoa Species 0.000 description 16
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 14
- 230000033001 locomotion Effects 0.000 description 13
- 230000009182 swimming Effects 0.000 description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 238000000034 method Methods 0.000 description 9
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 8
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 8
- 210000003205 muscle Anatomy 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 7
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 7
- 230000037396 body weight Effects 0.000 description 7
- 239000001103 potassium chloride Substances 0.000 description 7
- 235000011164 potassium chloride Nutrition 0.000 description 7
- 239000011691 vitamin B1 Substances 0.000 description 7
- 239000011715 vitamin B12 Substances 0.000 description 7
- 239000011716 vitamin B2 Substances 0.000 description 7
- 239000011726 vitamin B6 Substances 0.000 description 7
- 102000004420 Creatine Kinase Human genes 0.000 description 6
- 108010042126 Creatine kinase Proteins 0.000 description 6
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 6
- 230000003203 everyday effect Effects 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 229960000367 inositol Drugs 0.000 description 5
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 5
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 5
- 239000013589 supplement Substances 0.000 description 5
- DRBBFCLWYRJSJZ-UHFFFAOYSA-N N-phosphocreatine Chemical compound OC(=O)CN(C)C(=N)NP(O)(O)=O DRBBFCLWYRJSJZ-UHFFFAOYSA-N 0.000 description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- 244000269722 Thea sinensis Species 0.000 description 4
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 230000004118 muscle contraction Effects 0.000 description 4
- NEGYEDYHPHMHGK-UHFFFAOYSA-N para-methoxyamphetamine Chemical compound COC1=CC=C(CC(C)N)C=C1 NEGYEDYHPHMHGK-UHFFFAOYSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 206010021143 Hypoxia Diseases 0.000 description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 3
- 230000035565 breathing frequency Effects 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000036387 respiratory rate Effects 0.000 description 3
- 238000012549 training Methods 0.000 description 3
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 2
- LPOSZYSKJWFIQH-UHFFFAOYSA-N 2-aminoacetic acid;iron Chemical compound [Fe].NCC(O)=O LPOSZYSKJWFIQH-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 206010002660 Anoxia Diseases 0.000 description 2
- 241000976983 Anoxia Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000007953 anoxia Effects 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 2
- 235000011086 calcium lactate Nutrition 0.000 description 2
- 229960002401 calcium lactate Drugs 0.000 description 2
- 239000001527 calcium lactate Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000013068 control sample Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000037080 exercise endurance Effects 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 229960002442 glucosamine Drugs 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 230000028527 righting reflex Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 208000010444 Acidosis Diseases 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 208000025978 Athletic injury Diseases 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000168517 Haematococcus lacustris Species 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 102000008192 Lactoglobulins Human genes 0.000 description 1
- 108010060630 Lactoglobulins Proteins 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 206010039020 Rhabdomyolysis Diseases 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 206010041738 Sports injury Diseases 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 206010047924 Wheezing Diseases 0.000 description 1
- 108010093894 Xanthine oxidase Proteins 0.000 description 1
- 102100033220 Xanthine oxidase Human genes 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 230000007950 acidosis Effects 0.000 description 1
- 208000026545 acidosis disease Diseases 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000006538 anaerobic glycolysis Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 235000012730 carminic acid Nutrition 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000004098 cellular respiration Effects 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 210000003194 forelimb Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000000091 immunopotentiator Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000020786 mineral supplement Nutrition 0.000 description 1
- 229940029985 mineral supplement Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000035806 respiratory chain Effects 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 230000036391 respiratory frequency Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000019195 vitamin supplement Nutrition 0.000 description 1
- 235000021241 α-lactalbumin Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/20—Animal feeding-stuffs from material of animal origin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/132—Heterocyclic compounds containing only one nitrogen as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/22—Compounds of alkali metals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/50—Feeding-stuffs specially adapted for particular animals for rodents
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Animal Husbandry (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Birds (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Mycology (AREA)
- Fodder In General (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses a composition for helping pets improve athletic ability and promote recovery after exercise, belonging to the field of animal nutrition and health care. The raw materials of the composition comprise: energy donors, cardiac function aids, antioxidants, nutritional supplements, and functionalizing agents; the energy supply agent is a mixture of adenosine disodium triphosphate, creatine and glucose, and the cardiac function auxiliary agent is coenzyme Q10. The invention combines disodium adenosine triphosphate, creatine and glucose for use and simultaneously adds coenzyme Q10The sports equipment can effectively improve the sports ability of the pet and promote the recovery after sports.
Description
Technical Field
The invention belongs to the field of animal nutrition and health care, and particularly relates to a composition for helping pets to improve athletic ability and promote recovery after exercise.
Background
Modern people have high living pressure and fast working rhythm, and the accompanying of pets can relieve mental pressure to a certain extent, thereby bringing rapid development to pet economy. However, the idle time is short, so that the time for the pet to move is seriously compressed, and the health of the pet is not neglected. Survey showed that caged beagle dogs were sleeping or lying prone 60% of the time, sitting 11% of the time, and standing 26% of the time; studies by Hubrecht et al (1992) found that 60% of the time was immobile, while dogs raised alone reached 80%. The dog's primary sport is to play with the owner, but if the owner is not in contact with them, it is primarily focused on sunrise and sunset. Modern dog raising life is basically an activity of going out in the morning and evening, and the rest of the life is in the house, so that the exercise time of the dog is further shortened, and the great exercise amount is suddenly increased in a short activity time, so that the problems of exercise injury and recovery after exercise are easily caused to pets. The most important of them is the need of muscle energy reserve for short-time strenuous exercise, and the other is the recovery of the muscle after exercise. In life, after a common captive dog runs vigorously for a short time, the dog has the symptoms of low motor ability such as wheezing, paralysis and sitting, and even acidosis caused by lactic acid accumulation accelerates the excretion of potassium, thereby causing potassium ion deficiency in cells and motor rhabdomyolysis.
Patent CN104982714A discloses a sports beverage for pet dogs and a preparation method thereof, wherein the sports beverage comprises the following components in parts by weight: 1-5 parts of dipotassium hydrogen phosphate, 1-5 parts of potassium chloride, 2-4 parts of calcium lactate, 0.5-2 parts of magnesium sulfate and vitamin B11-5 parts of vitamin B22-10 parts of malto-oligosaccharide, 50000-80000 parts of a flavoring agent, 20-30 parts of potassium sorbate, 2-6 parts of lemon yellow and 2-6 parts of carmine.
Patent CN101204199A discloses a pet dog beverage additive and a dog beverage prepared from the same, which mainly comprises calcium lactate and vitamin B1Vitamin B2Vitamin B3Vitamin B6Vitamin B12Folic acid, aloe juice.
Patent CN103082276A discloses a composition for reducing and promoting sports injury repair, which contains the following raw and auxiliary materials in parts by weight: 500-2000 parts of hydrolyzed collagen, 100-400 parts of soybean protein peptide, 50-400 parts of chondroitin sulfate, 50-400 parts of glucosamine or salt thereof, 10-1000 parts of traditional Chinese medicine, 10-400 parts of haematococcus pluvialis, 1-100 parts of vitamin and 1-100 parts of mineral substance.
The existing patent applications are mostly based on vitamin and mineral supplement, and chondroitin and glucosamine are also supplemented to solve the problem of joints. However, the current pet dog feeding mode is mainly used for improving the exercise capacity and solving the problems of insufficient muscle energy supply caused by short-time strenuous exercise and muscle recovery after exercise for the exercise difficulty, so the scheme cannot solve the problem.
Therefore, aiming at the existing pet raising mode, starting from the aspects of improving the energy supply in the motion state, improving the motion capability of the pet, reducing the motion injury, recovering after the motion and the like, the problem of muscle injury caused by the motion of the pet is thoroughly improved, and the problem is the problem which is urgently needed to be solved for pet raising.
The term "pet" refers to all animals kept at home that produce spiritual trusting, interactive entertainment, companionship, etc., such as dogs, pigs, cats, hamsters, guinea pigs, rabbits, etc., in humans.
Disclosure of Invention
Aiming at the problems of improving the athletic ability and recovering after exercise in the existing pet feeding mode, the invention provides the composition for helping the pet improve the athletic ability and promoting the recovery after exercise, which can effectively improve the athletic ability of the pet and promote the recovery after exercise.
In order to achieve the purpose, the invention adopts the following technical scheme:
a composition for helping pets improve athletic ability and promote recovery after exercise comprises the following raw materials in percentage by weight: 10-50% of energy supply agent, 0.05-2% of cardiac function auxiliary agent, 0.5-5% of antioxidant, 5-20% of nutritional supplement and 5-75% of functionalizing agent, wherein the sum of the weight percentages of all the raw materials is 100%;
the energy supply agent is a mixture of disodium adenosine triphosphate, creatine and glucose;
the cardiac function auxiliary agent is coenzyme Q10;
The nutritional supplement is hydrolyzed whey protein powder;
the functionalizing agent is selected from amino acids, vitamins, mineral elements, taste enhancers or dietary fibers.
Further, the weight ratio of the disodium adenosine triphosphate to the creatine in the energy supplying agent is 5:1 to 1:50, and the weight ratio of the sum of the weight of the disodium adenosine triphosphate and the weight of the creatine to glucose is 2:1 to 1: 10.
Further, the weight ratio of the disodium adenosine triphosphate to the creatine in the energy supplying agent is 2: 1-1: 30, the weight ratio of the sum of the weight of the disodium adenosine triphosphate and the weight of the creatine to the weight of the glucose is 1: 1-1: 5.
The energy sources required for the life activities of the body mainly include sugar, fat and protein, and the energy sources required for muscle contraction are mainly generated by the anaerobic and aerobic metabolic pathways of the above substances. Adenosine Triphosphate (ATP) can be directly used by muscle contraction as an energy source substance, when ATP is consumed in muscle contraction, creatine kinase can hydrolyze creatine phosphate to generate creatine, high-energy phosphate converts ADP into ATP, but when creatine phosphate is consumed in strenuous exercise, AMP is generated in the process of converting ADP into ATP, and then the AMP is decomposed into ammonia, hypoxanthine and uric acid by xanthine oxidase, and simultaneously active oxygen (ROS) is generated, so that the body generates oxidative stress and then generates a series of in vivo peroxidation reactions. ATP is stored in animals in very small quantities, and during exercise, ATP is consumed quickly, and creatine can be quickly resynthesized into ATP to supply energy. Glucose is an indispensable nutrient for metabolism in organisms, is easily absorbed into blood, and is often used as a strong and powerful rapid energy supplement. Although oral supplementation of creatine can increase creatine concentrations in resting muscles with lower creatine concentrations, the Scott et al (1999) study found that supplementation of creatine with 2.5g creatine per day and continued for 6 weeks had no effect on total muscle creatine concentrations and running speed compared to control dogs not supplemented with creatine.
Coenzyme Q10Plays an important role in proton translocation and electron transfer in the respiratory chain in vivo, and is an activator of cellular respiration and cellular metabolism, and also an important antioxidant and nonspecific immunopotentiator. It can provide sufficient motive force for heart to keep it in good operation state, so as to relieve its anoxia.
The invention discovers that disodium adenosine triphosphate, creatine and glucose are used together and coenzyme Q is added simultaneously10Can effectively improve the exercise capacity and tolerance of the animals in short-time violent exercise. But used aloneThis effect has not been reported.
Meanwhile, the hydrolyzed whey protein powder is selected as the nutritional supplement because the components of the hydrolyzed whey protein powder comprise alpha-lactalbumin, beta-lactoglobulin, serum albumin, immunoglobulin, a small amount of lactoferrin and the like, and the hydrolyzed whey protein powder is easy to absorb, can help to control the body weight, improve the muscle quality, promote the bone growth, enhance the immunity and has good effects on the aspects of fatigue resistance and the like.
In addition, the functionalizing agent can provide necessary amino acid, vitamin and mineral elements for life activities, improve the internal environment of the intestinal tract of the pet and help digestion, wherein the taste enhancer is derived from the dried animal meat product and is used for improving the mouthfeel of the pet.
Further, the amino acid is taurine.
Further, the natural antioxidant is selected from d-alpha-tocopherol acetate, L-ascorbic acid or tea polyphenol.
Furthermore, the composition for helping pets improve the athletic ability and promote recovery after exercise comprises the following raw materials in percentage by weight: 20-40% of energy supply agent, 0.2-1% of cardiac function auxiliary agent, 0.5-5% of antioxidant, 10-20% of nutritional supplement and 5-60% of functionalizing agent, wherein the sum of the weight percentages of all the raw materials is 100%.
At present, for nutritional health products used before and after the movement of pets, firstly, the taste regulator induces the pets to drink water to supplement water; and the second is to use the nutrient elements containing amino acid, vitamin, mineral elements and the like to supplement the nutrient elements lost due to exercise. Only the water and the nutrients lost due to the movement are supplemented, and no solution is provided for the improvement of the movement capacity and the recovery of the body after the movement required by the short-time violent movement of the pet in the current captive state. In the composition of the present invention, coenzyme Q10Can provide sufficient motive power for the heart and relieve the hypoxia condition of the heart; the energy combination of the adenosine disodium triphosphate, the creatine and the glucose can provide direct, rapid and continuous energy supply for body movement; can be reduced by adding natural d-alpha-tocopherol acetate, L-ascorbic acid, and tea polyphenolsDamage to proteins, fats and nucleic acids by free radicals and ROS produced by exercise; meanwhile, the whey protein improves the muscle quality, and supplements amino acid, vitamins and mineral substances to supplement nutrient elements lost along with water in the exercise process.
The composition of the invention can be prepared into different forms of oral dosage forms according to eating habits and convenience of different animals when used on site and according to a method well known by a person skilled in the art.
The use method of the composition can be used 30 minutes before or after the pet exercises.
Compared with the conventional products, the composition of the invention has the following advantages and beneficial effects: (1) providing a three-dimensional energy supply mode for pet movement from an energy supply angle, and ensuring the energy requirement of muscle contraction; (2) maintaining cardiac function, relieving anoxia, and reducing anaerobic glycolysis of saccharide; (3) supplementing nutrients lost during exercise.
Detailed Description
The following examples further illustrate the present invention but are not to be construed as limiting the invention. Modifications or substitutions to methods, procedures, or conditions of the invention may be made without departing from the spirit and scope of the invention. The experimental methods and the ingredients of the formulations not specified in the examples are in accordance with the conventional conditions in the art.
Example 1
The composition for helping the pet improve the athletic ability and promote the recovery after exercise, provided by the invention, comprises the following raw materials in parts by weight: disodium adenosine triphosphate 0.5 wt%, creatine 10 wt%, glucose 28 wt%, coenzyme Q100.5 percent of d-alpha-tocopherol acetate, 0.5 percent of L-ascorbic acid, 2 percent of hydrolyzed whey protein powder, 0.5 percent of taurine, 0.2 percent of inositol, 0.3 percent of nicotinamide and vitamin B60.02% of vitamin B120.0002 percent, 0.5 percent of potassium chloride, 1 percent of sodium chloride, 15 percent of xylo-oligosaccharide and 20.9798 percent of chicken powder, and the components are uniformly mixed and pressed into tablets. 1-3 g of the composition is orally taken per 10kg of body weight every day.
Example 2
The other composition for helping the pet improve the athletic ability and promote the recovery after the exercise, which is disclosed by the invention, comprises the following raw materials in parts by weight: disodium adenosine triphosphate 1 wt%, creatine 8 wt%, glucose 25 wt%, coenzyme Q100.8 percent of d-alpha-tocopherol acetate, 1 percent of L-ascorbic acid, 15 percent of hydrolyzed whey protein powder, 1 percent of taurine, 0.5 percent of inositol, 0.5 percent of nicotinamide, and vitamin B10.02% of vitamin B20.03 percent and vitamin B60.04% and vitamin B120.0004 percent, 0.7 percent of potassium chloride, 1.5 percent of sodium chloride, 10 percent of xylo-oligosaccharide and 30.9096 percent of chicken powder, and evenly mixing the components into powder. 1-3 g of the composition is orally taken per 10kg of body weight every day.
Example 3
The invention also provides a composition for helping pets improve athletic ability and promote recovery after exercise, which comprises the following raw materials in parts by weight: disodium adenosine triphosphate 3 wt%, creatine 7 wt%, glucose 28 wt%, coenzyme Q101 percent of d-alpha-tocopherol acetate, 1 percent of L-ascorbic acid, 14 percent of hydrolyzed whey protein powder, 1 percent of taurine and vitamin B10.06 percent and vitamin B20.07% of vitamin B60.06 percent and vitamin B120.0004 percent, 0.6 percent of potassium chloride, 1.2 percent of sodium chloride, 15 percent of xylo-oligosaccharide, 24.0096 percent of chicken powder, and wet mixing the components into semisolid paste by using drinking water with 30 percent of dry matter. 1-3 g of the composition is orally taken per 10kg of body weight every day.
Example 4
The invention also provides another composition for helping pets improve athletic ability and promote recovery after exercise, which comprises the following raw materials in parts by weight: disodium adenosine triphosphate 1.5 wt%, creatine 6 wt%, glucose 20 wt%, coenzyme Q100.6 percent of d-alpha-tocopherol acetate, 0.8 percent of tea polyphenol, 2 percent of hydrolyzed whey protein powder, 1 percent of taurine, 0.3 percent of inositol, and vitamin B10.05% and vitamin B20.05% and vitamin B60.03 percent and vitamin B120.0003 percent, 1 percent of glycine iron, 0.5 percent of potassium chloride, 1 percent of sodium chloride, 12 percent of xylo-oligosaccharide and 33.1697 percent of beef powder, and evenly mixing and pressing into tablets. Orally administered 1-3 times per 10kg body weight per dayg。
Comparative example 1
The raw materials are as follows: 30 percent of glucose (weight percentage, the same below), 0.8 percent of d-alpha-tocopherol acetate, 2 percent of tea polyphenol, 20 percent of hydrolyzed whey protein powder, 1 percent of glycine iron, 1 percent of taurine, 0.3 percent of inositol, and vitamin B10.05% and vitamin B20.05% and vitamin B60.03 percent and vitamin B120.0003 percent, 0.5 percent of potassium chloride, 1 percent of sodium chloride, 12 percent of xylo-oligosaccharide and 31.2697 percent of beef powder, and evenly mixing and pressing into tablets. 1-3 g of the composition is orally taken per 10kg of body weight every day.
Comparative example 2
The raw materials are as follows: disodium adenosine triphosphate 5% (by weight, the same applies below), coenzyme Q101 percent of d-alpha-tocopherol acetate, 1 percent of L-ascorbic acid, 20 percent of hydrolyzed whey protein powder, 1 percent of taurine, 0.5 percent of inositol, and vitamin B10.05% and vitamin B20.05%, nicotinamide 0.5%, vitamin B60.03 percent and vitamin B120.0004 percent, 0.6 percent of potassium chloride, 1 percent of sodium chloride, 15 percent of xylo-oligosaccharide and 49.2696 percent of chicken powder, and the components are uniformly mixed and pressed into tablets. 1-3 g of the composition is orally taken per 10kg of body weight every day.
Test example 1
Composition test for helping pets improve athletic ability and promote recovery after exercise according to the present invention
(I) test materials
(1) Test samples: samples prepared in example 1 (group I) and example 3 (group II).
(2) Control sample: samples prepared in comparative example 1 (group III), comparative example 2 (group IV).
(3) Test animals: healthy SPF-grade Wistar male rats weigh 180-200 g.
(II) test method
Rats were randomly divided into 4 groups of 10 animals each one week after acclimatization, each group was divided into group I (example 1), group II (example 3), group III (comparative example 1), and group IV (comparative example 2), and each group was fed with 2g of the product per day for the rest of the time, and the regular diet was continued for 21 days. Swimming training is carried out every day, when training, the tail of the rat bears a load of 5 percent of weight, and the rat is placed in a swimming box for swimming, the water temperature is 25 +/-0.5℃, and the training is stopped after the rat is exhausted. The standard for judgment of exhaustion is that rats sink in water for more than 10s and cannot complete righting reflex when placed on a plane.
Swimming test: after the rats are used for 30min for the last time, randomly taking 5 rats in each group for carrying out a no-load swimming test, putting the rats into a swimming box for swimming, and observing the time from swimming to exhaustion of the rats at the water temperature of 25 +/-0.5 ℃. The standard for judgment of exhaustion is that rats sink in water for more than 10s and cannot complete righting reflex when placed on a plane.
Blood Lactate (BLA), blood Lactate Dehydrogenase (LDH), blood Creatine Kinase (CK), Blood Urea Nitrogen (BUN) assay: after the rats are used for 30min for the last time, randomly taking 5 rats in each group, placing the rats in a swimming pool for swimming for 60min without load, taking out the rats, taking blood by an orbital bleeding method after resting for 10min, and measuring the BLA content, the blood LDH activity, the blood CK activity and the blood BUN content according to a kit method.
(III) test results
The test results are shown in tables 1-2.
TABLE 1 rat weight bearing swimming time
Group of | Number of animals/n | Swimming time/min |
Group I | 5 | 96.9±4.48a |
Group II | 5 | 98.3±8.16a |
Group III | 5 | 78.7±6.34b |
Group IV | 5 | 81.4±5.32b |
Note: the difference between the capital and small letters in the shoulder marks of the data in the same column indicates significant difference (P <0.05), and the difference between the capital and small letters indicates significant difference (P <0.01), which is the same below.
TABLE 2 Effect of biochemical blood indices after rat swimming
According to the test results, the products of the examples 1 and 3 can obviously increase the exercise endurance of animals and obviously improve the exercise time of the animals. Meanwhile, the blood biochemical indexes show that the products of the examples 1 and 3 are remarkably or extremely remarkably superior to the products of the comparative examples 1 and 2 in the main indexes related to sports, such as Blood Lactate (BLA), blood Lactate Dehydrogenase (LDH), blood Creatine Kinase (CK), Blood Urea Nitrogen (BUN) and the like. Improvement of these indicators is important to improve the performance and recovery after exercise of animals.
Test example 2
Composition test for helping pets improve athletic ability and promote recovery after exercise according to the present invention
(I) test materials
(1) Test samples: samples prepared in example 1 (group I) and example 3 (group II)
(2) Control sample: sample prepared in comparative example 1 (group III)
(3) Test animals: the breed comprises 3 golden retrievers, 4 border shepherds and 5 Teddy dogs, and the age is 2-4 years old.
(II) test method
12 healthy dogs were randomly divided into three groups of 4 dogs, each fed test and control samples, and the specific groups are shown in Table 3. The test measurements were carried out after 2 weeks of continuous feeding according to the feeding method listed in Table 3. Measuring the respiratory rate of the dog before exercise, and measuring the time taken for the respiratory rate to return to a normal level (respiratory rate before exercise) after exercise; and collecting venous blood of forelimb before and 30min after exercise, and measuring blood lactate, urea nitrogen, and lactate dehydrogenase. The test scheme is that the dog is enabled to continuously move for 30 minutes in modes of induction, forecourt and the like, and the movement distance is not less than 5 km.
TABLE 3 test grouping and treatment
(III) test results
The test results are shown in tables 4-5.
TABLE 4 change of breathing frequency before and after exercise
Grouping | Test sample | Breathing frequency before exercise (times/min) | Recovery of breathing frequency time (min) after exercise |
Group I | Example 1 | 23.0±2.6 | 9.5±1.3 |
Group II | Example 3 | 24.0±2.6 | 9.5±2.1 |
Group III | Comparative example 1 | 23.8±3.3 | 13.3±1.7* |
Note: indicates significant differences (p <0.05), as follows.
TABLE 5 Change in Biochemical indicators before and after exercise
According to the test results, the average respiratory frequency before the exercise of each test group is not different, but the time taken for the exercise to return to the normal level is obviously longer than that of the example 1 and the example 2 in the comparison example 1, which shows that the example 1 and the example 2 can obviously promote the recovery after the exercise of the dog. From the biochemical index, the serum lactic acid level of the dog in the comparative example 1 is obviously higher than that of the dog in the example 1 and the dog in the example 2 after exercise, simultaneously, the lactate dehydrogenase activity is obviously lower than that of the dog in the example 1 and the dog in the example 2, but the urea nitrogen level is not obviously different, and from the result analysis, the accumulation of the lactic acid in the body of the dog in the test groups in the example 1 and the dog in the test group in the example 3 after exercise is obviously lower than that of the comparative example, which also indicates that the exercise tolerance of the animal can be obviously improved.
The results of two experimental examples show that the composition of the invention can remarkably improve the exercise endurance of animals, remarkably improve the exercise capacity of the animals, promote the recovery after exercise and the like by providing a three-dimensional energy supply mode, improving the heart function of the animals and supplementing antioxidant and taurine.
Claims (7)
1. A composition for aiding in the enhancement of athletic performance and promoting recovery after exercise in a pet, comprising: the raw materials comprise the following components in percentage by weight: 10-50% of energy supply agent, 0.05-2% of cardiac function auxiliary agent, 0.5-5% of antioxidant, 5-20% of nutritional supplement and 5-75% of functionalizing agent, wherein the sum of the weight percentages of all the raw materials is 100%;
the energy supply agent is a mixture of disodium adenosine triphosphate, creatine and glucose;
the cardiac function auxiliary agent is coenzyme Q10;
the nutritional supplement is hydrolyzed whey protein powder;
the functionalizing agent is selected from amino acids, vitamins, mineral elements, taste enhancers or dietary fibers.
2. The composition of claim 1, wherein: the raw materials comprise the following components in percentage by weight: 20-40% of energy supply agent, 0.2-1% of cardiac function auxiliary agent, 0.5-5% of antioxidant, 10-20% of nutritional supplement and 5-60% of functionalizing agent, wherein the sum of the weight percentages of all the raw materials is 100%.
3. The composition according to claim 1 or 2, characterized in that: the weight ratio of the disodium adenosine triphosphate to the creatine in the energy supplying agent is 5: 1-1: 50, and the weight ratio of the sum of the weight of the disodium adenosine triphosphate and the weight of the creatine to the weight of the glucose is 2: 1-1: 10.
4. The composition of claim 3, wherein: the weight ratio of the disodium adenosine triphosphate to the creatine in the energy supply agent is 2: 1-1: 30, the weight ratio of the sum of the weight of the disodium adenosine triphosphate and the weight of the creatine to the weight of the glucose is 1: 1-1: 5.
5. The composition according to claim 1 or 2, characterized in that: the amino acid is taurine.
6. The composition according to claim 1 or 2, characterized in that: the natural antioxidant is selected from d-alpha-tocopherol acetate, L-ascorbic acid or tea polyphenol.
7. Use of a composition according to claim 1 for the manufacture of an oral pet product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111307564.6A CN114190476A (en) | 2021-11-05 | 2021-11-05 | Composition for helping pets to improve athletic ability and promote recovery after exercise |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111307564.6A CN114190476A (en) | 2021-11-05 | 2021-11-05 | Composition for helping pets to improve athletic ability and promote recovery after exercise |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114190476A true CN114190476A (en) | 2022-03-18 |
Family
ID=80646949
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111307564.6A Pending CN114190476A (en) | 2021-11-05 | 2021-11-05 | Composition for helping pets to improve athletic ability and promote recovery after exercise |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114190476A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107485019A (en) * | 2017-08-16 | 2017-12-19 | 东北农业大学 | It is a kind of quick to regain one's strength and increase the compound health powder of flesh |
CN108114006A (en) * | 2018-01-30 | 2018-06-05 | 河南中盛动物药业有限公司 | A kind of preparation containing trinosin |
CN109105702A (en) * | 2018-08-30 | 2019-01-01 | 泓博元生命科技(深圳)有限公司 | A kind of preparation method of composition containing NADH, application and energy extender |
-
2021
- 2021-11-05 CN CN202111307564.6A patent/CN114190476A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107485019A (en) * | 2017-08-16 | 2017-12-19 | 东北农业大学 | It is a kind of quick to regain one's strength and increase the compound health powder of flesh |
CN108114006A (en) * | 2018-01-30 | 2018-06-05 | 河南中盛动物药业有限公司 | A kind of preparation containing trinosin |
CN109105702A (en) * | 2018-08-30 | 2019-01-01 | 泓博元生命科技(深圳)有限公司 | A kind of preparation method of composition containing NADH, application and energy extender |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jansson et al. | A forage-only diet alters the metabolic response of horses in training | |
CN102318777B (en) | N-3 fatty acid enriched laying hen feed and production method thereof | |
Kreider et al. | Protein for exercise and recovery | |
Halls | Nutritional requirements for rabbits | |
JP5027501B2 (en) | Nutritional supplement food for active animals | |
Frape | Diet and exercise performance in the horse | |
CN111134244A (en) | Animal high-protein nutritional paste and preparation method thereof | |
De Rodas et al. | L-ascorbyl-2-polyphosphate as a vitamin C source for segregated and conventionally weaned pigs | |
CN101715892A (en) | Compound premix for improving pork quality | |
CN101690591A (en) | Yak marrow polypeptide bone growing and height increasing tablets (powder) | |
Harris et al. | Nutritional management of elite endurance horses | |
Davarmanesh et al. | Effect of Ca-butyrate and Oleobiotec (a flavouring agent) supplemented starter on the performance of Holstein dairy calves | |
CN114190476A (en) | Composition for helping pets to improve athletic ability and promote recovery after exercise | |
Hernandez-Calva et al. | Influence of dietary magnesium and selenium levels in finishing diets on growth performance and carcass meat quality of feedlot Pelibuey lambs | |
Wang et al. | Effects of iron injection at birth on neonatal iron status in young pigs from first-parity sows fed delta-aminolevulinic acid | |
CN1813794A (en) | Lead-removing growth-assisting tablet and its preparing method | |
Omar et al. | Economic assessment of various levels of protein and energy in pigeon squabs diet | |
CN112806488A (en) | Special premix for breeding ewes | |
KR100647085B1 (en) | The production method of taurine enriched pork by supplementation of feather meal and thereof the pork | |
CN107432373A (en) | A kind of ox feed and preparation method thereof | |
Krider et al. | Sardine condensed fish solubles and rye pasture for sows during gestation and lactation | |
RU2368251C2 (en) | Food and feed supplements and application thereof | |
Partama | Inclusion of dietary multi-mineral-vitamin (“Pignox”) on growth performance in weaned piglet | |
Annicchiarico et al. | Dietary intake of vitamins and minerals, and water requirements. | |
Fisher et al. | Counteracting the growth retardation of raw soybean meal with extra protein and calories |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220318 |
|
RJ01 | Rejection of invention patent application after publication |